TATI (tumour-associated trypsin inhibitor) as a marker of ovarian cancer.

In ovarian cancer patients a 6 kDa polypeptide, the tumour-associated trypsin inhibitor (TATI), can occur at elevated concentrations in both urine and serum. In this study pretreatment serum levels of TATI (cut-off point 21 ng ml-1) and CA 125 (cut-off points 35 U ml-1 and 65 U ml-1) were determined...

Descripción completa

Detalles Bibliográficos
Autores principales: Medl, M., Ogris, E., Peters-Engl, C., Leodolter, S.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1995
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033783/
https://www.ncbi.nlm.nih.gov/pubmed/7734298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033783/
https://www.ncbi.nlm.nih.gov/pubmed/7734298

Ejemplares similares